Bibliographic Citation
| - Hopkins Paul N., Defesche Joep, Fouchier Sigrid W., Bruckert Eric, Luc Gérald, Cariou Bertrand, Sjouke Barbara, Leren Trond P., Harada-Shiba Mariko, Mabuchi Hiroshi, Rabès Jean-Pierre, Carrié Alain, Heyningen Charles, Carreau Valérie, Farnier Michel, Teoh Yee P., Bourbon Mafalda, Kawashiri Masa-Aki, Nohara Atsushi, Soran Handrean, Marais A. David, Tada Hayato, Abifadel Marianne, Boileau Catherine, Chanu Bernard, Katsuda Shoji, Kishimoto Ichiro, Lambert Gilles, Makino Hisashi, Miyamoto Yoshihiro, Pichelin Matthieu, Yagi Kunimasa, Yamagishi Masakazu, Zair Yassine, Mellis Scott, Yancopoulos George D., Stahl Neil, Mendoza Johanna, Du Yunling, Hamon Sara, Krempf Michel, Swergold Gary D.. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circulation: Genomic and Precision Medecine, 2015, Equipe 5, 8 (6), pp.823--831. ⟨10.1161/CIRCGENETICS.115.001129⟩
- Hopkins Paul N., Bruckert Eric, Luc Gérald, Cariou Bertrand, Sjouke Barbara, Harada-Shiba Mariko, Rabès Jean-Pierre, Carrié Alain, Carreau Valérie, Farnier Michel, Abifadel Marianne, Boileau Catherine, Chanu Bernard, Lambert Gilles, Pichelin Matthieu, Zair Yassine, Krempf Michel. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circulation: Genomic and Precision Medecine, 2015, Equipe 5, 8 (6), pp.823--831. ⟨10.1161/CIRCGENETICS.115.001129⟩
|